Sublingual immunotherapy for allergic respiratory diseases: An evaluation of meta-analyses Nieto A et al. - Because of discrepancies, inconsistencies, and lack of robustness, the MAs on sublingual immunotherapy do not provide enough evidence to support its current routine management in patients with allergic asthma or rhinoconjunctivitis. Sensitivity to potential publication bias should be tested and reported in all MAs. [more...]
